Kyowa Kirin, Knight Therapeutics Enter Distribution Deal For POTELIGEO In Latin America
(RTTNews) - Tuesday, Kyowa Kirin (4151.T) said it entered into an exclusive distribution agreement with Knight Therapeutics (GUD.TO) for POTELIGEO (mogamulizumab) in select Latin American countries.